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detected in any of the 40 nevi tested, either by TaqI digestion
(Fig 2a) or by MSP-PCR (Fig 2b).
Our results suggest little or no involvement of genetic or
epigenetic alterations of CDKN2A in nevus etiology, and thus
support the data of others who have failed to detect CDKN2A
mutation (Healy et al, 1996b) or methylation (Gonzalgo et al, 1997)
in various types of nevi; however, our ®ndings do not rule out
mutations in noncoding regions nor factors other than methylation
affecting expression of this gene. Alternatively, variations in
noncoding regions of CDKN2A or in a gene adjacent to
CDKN2A may account for the variance in nevus count we have
shown to be linked to this region (Zhu et al, 1999).
We thank Georgia Chenevix-Trench for initiating this collaboration, supported by
grants from the Queensland Cancer Fund, the National Health and Medical
Research Council (950998, 961061, and 981339), and the Cooperative Research
Center for Discovery of Genes for Common Human Diseases.
John Welch, Doug Millar,* Alana Goldman, Peter Heenan,²
Mitchell Stark, Michael Eldon,² Susan Clark,*
Nicholas G. Martin, Nicholas K. Hayward
Joint Experimental Oncology Programme of the Queensland
Institute of Medical Research, the University of Queensland, and
the Queensland Cancer Fund, P.O. Royal Brisbane Hospital,
Queensland, Australia
*CSIRO Molecular Sciences, North Ryde,
New South Wales, Australia
²Cutaneous Pathology, Nedlands, Western Australia, Australia
REFERENCES
Aitken J, Welch J, Duffy D, Milligan M, Martin N, Green A, Hayward NK:
CDKN2A mutations and polymorphisms and melanoma risk in a population-
based sample of Queensland families with cutaneous melanoma. J Natl Cancer
Inst 91:446±452, 1999
Cannon-Albright LA, Meyer W, Goldgar DE, Lewis CM, Zone JJ, Skolnick MH:
Penetrance and expressivity of the chromosome 9p melanoma susceptibility
locus (MLM). Cancer Res 54:6041±6044, 1994
Clark S, Harrison J, Paul CL, Frommer MR: High sensitivity mapping of methylated
cytosines. Nucl Acids Res 22:2990±2997, 1994
Foulkes W, Flanders TY, Pollock P, Hayward NK: CDKN2A and cancer. Mol
Medical 3:5±20, 1997
Gonzalgo ML, Bender CM, You EH, et al: Low frequency of p16/CDKN2A
methylation in sporadic melanoma: comparative approaches for methylation
analysis of primary turnors. Cancer Res 57:5336±5347, 1997
Greene MH, Clark YM Jr, Tucker MA, Kraemer KH, Elder DE, Fraser MC: High
risk of malignant melanoma in melanoma-prone families with dysplastic nevi.
Ann Intern Med 102:458±465, 1985
Gruis NA, Sandkuijl LA, van der Velden PA, Bergman W, Frants RR: CDKN2
explains part of the clinical phenotype in Dutch familial atypical multiple-mole
melanoma (FAMMM) syndrome families. Melanoma Res 5:169±177, 1995
Hayward NK: The current situation with regard to human melanoma and genetic
inferences. Curr Opin Oncol 8:136±142, 1996
Healy E, Belgaid CE, Takata M, Vahlquist A, Rehman I, Rigby H, Rees JL:
Allelotypes of primary cutaneous melanoma and benign melanocytic nevi.
Cancer Res 56:589±593, 1996a
Healy E, Sikkink S, Rees JL: Infrequent mutation of p161NK4 in sporadic
melanoma. J Invest Dermatol 107:318±321, 1996b
Huschtscha LI, Noble JR, Neumann AA, et al: Loss of p161NK4 expression by
methylation is associated with lifespan extension of human mammary epithelial
cells. Cancer Res 58:3508±3512, 1998
Kamb A, Gruis NA, Weaver-Feldhaus J, et al: A cell cycle regulator potentially
involved in genesis of many tumor types. Science 264:436±440, 1994
Lee JY, Dong SM, Shin MS, et al: Genetic alterations of p161NK4a and p53 genes in
sporadic dysplastic nevus. Biochem Biophys Res Commun 237:667±672, 1997
Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA: Deletions of the
cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature
368:753±756, 1994
Platz A, Hansson J, Mansson-Brahme E, et al: Screening of germline mutations in the
CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous
melanoma. J Natl Cancer Inst 89:697±702, 1997
Pollock PM, Spurr N, Bishop T, et al: Haplotype analysis of two recurrent CDKN2A
mutations in 10 melanoma families: evidence for common founders and
independent mutations. Hum Mutat 11:424±431, 1998
Ruas M, Peters G: The pl61NK4a/CDKN2A tumor suppressor and its relatives.
Biochim Biophys Acta 1378:F115±F177, 1998
Swerdlow AJ, Green AC: Melanocytic nevi and melanoma: an epidemiologic
perspective. Br J Dermatol 117:137±146, 1987
Warnecke PM, Stirzaker C, Melki JR, Millar DS, Paul CL, Clark SJ: Detection and
measurement of PCR bias in quantitative methylation analysis of bisulphite-
treated DNA. Nucl Acids Res 25:4422±4426, 1997
Zhu G, Duffy DL, Eldridge A, et al: A major quantitative-trait locus for mole density
is linked to the familial melanoma gene CDKN2A. a maximum-likelihood
combined linkage and association analysis in twins and their sibs. Am J Hum
Genet 65:483±492, 1999
Real-Time Evidence of In Vivo Leukocyte Traf®cking in
Human Skin by Re¯ectance Confocal Microscopy
To the Editor:
The dynamic sequence of events mediating leukocyte emigration
from vascular to tissue compartments, including lymphocyte
homing and localization of monocytes and neutrophils in in¯amed
tissue, is directed by adhesive molecules and molecular signals that
result in the attachment/rolling of leukocytes followed by their
strong adhesion/arrest and diapedesis (Sackstein et al, 1988; Shimizu
et al, 1992; Springer, 1994; Clark and Brugge, 1995; Sackstein,
1995). To date, this multistep process has been investigated utilizing
in vitro and in vivo experimental models requiring invasive
procedures such as multiple biopsies to allow ex vivo histologic
analysis of emigrated leukocytes and, more recently, by intravital
Figure 2. Methylation analysis of the p16 promoter region. (A)
DNA from nevus samples (1±9) was bisul®te-treated and ampli®ed with
primers that amplify methylated and unmethylated DNA in proportion.
The PCR was either undigested (U) or digested with TaqI (C).
Methylated p16 DNA was ampli®ed as a control from bisul®te-treated
human DNA that had been spiked at 10%, 25%, and 50% levels
(Warnecke et al, 1997). Lane M; DNA size markers. (B) DNA from
nevus samples (1±16) was bisul®te-treated and ampli®ed using MSP-
PCR primers. Methylated p16 DNA was ampli®ed as a control from
bisul®te-treated human DNA that had been spiked at 0.1% (+) and 1%
(++) and not spiked as a negative control (±).
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microscopy after intravenous administration of ¯uorescently labeled
peripheral blood cells in animals (Lawrence and Springer, 1991;
Bargatze et al, 1995; von Andrian, 1996; Robert et al, 1999).
Excisional biopsy permanently changes the native tissue and
eventuates in scarring; moreover, most of the ¯uorescent dyes for
studying blood cell ¯ow within vasculature at high resolution are
toxic and thus not approved for human use by the FDA.
Recent advances in re¯ectance confocal microscopy (CM) have
resulted in the development of real-time, near-infrared confocal
scanning laser microscopes that yield real-time high resolution
optical sections of human or animal skin in its native state in vivo
(Rajadhyaksha et al, 1995, > 1999). Similarly, tandem scanning
confocal microscopy has been applied for imaging human skin
in vivo (New et al, 1991; Corcuff et al, 1993). Optical re¯ectance
imaging relies on the natural variations in refractive indices of tissue
microstructures for contrast. Nuclear- and cellular-level detail can
be imaged with a resolution comparable with routine histology to a
depth that includes papillary and upper reticular dermis. Imaging is
obtained at video-rate (30 frames per s), allowing high temporal
resolution (33 milliseconds per frame) for visualizing dynamic
processes such as the time sequence of histologic events during
eczematous reaction (e.g., spongiosis with microvesicle formation
and dermal vasodilation) (GonzaÂlez et al, 1999a), and those
occurring after laser-treatment of vascular lesions (GonzaÂlez et al,
1999b; Agashi et al, 2000).
Real-time observation of peripheral blood cells ¯owing through
capillary loops of healthy human skin and oral mucosa in vivo has
been previously reported (Rajadhyaksha et al, 1995, 1999; GonzaÂlez
et al, 1999a; White et al, 1999). Based on size, shape, and number
density, peripheral blood cells on live images and grabbed images
could be identi®ed; however, analysis of leukocyte emigration from
vascular to tissue compartments was not performed. In this letter,
we report the capability to observe leukocyte±endothelial inter-
actions in native human skin in vivo at video-rate with a confocal
scanning laser microscope. This methodology makes possible the
real-time analysis of the traf®cking of human leukocytes in vivo.
Near-infrared CM can image live hemodynamic cellular events
in in¯ammatory conditions (e.g., sunburn, psoriasis, skin cancer),
including tethering and rolling of leukocytes on the endothelial
wall, with adhesion and arrest to the endothelium. In our clinical
studies, we consistently observe this in basal cell carcinomas in vivo
(Fig 1). Because the tissue is not harmed, high-resolution CM
imaging can be performed frequently and repeatedly, and therefore
evaluation of various stages of adhesive interactions between
leukocytes and skin endothelium can be investigated in vivo.
This novel imaging tool opens new avenues of investigating
dynamic events in real time and noninvasively. The potential of
confocal imaging to noninvasively view blood ¯ow, and elucidate
adhesive interactions and histology, may lead to new criteria for
diagnosis of cutaneous diseases and may facilitate treatment and
management of signi®cant medical problems where conventional
histopathology does not provide a de®nitive diagnosis. A good
example is acute cutaneous graft-versus-host disease (GvHD), a
major life-threatening complication of allogeneic bone marrow
transplantation faces this challenge. This entity does not have
pathognomonic histologic features. Dermal lymphocytic in®ltrates,
mediated by discrete leukocyte±endothelial interactions occurring
in the target tissue, are a hallmark of cutaneous GvHD and are the
earliest feature of this condition (Sackstein, 1995). The capability to
observe emigration of lymphocytes in vivo in the early post-
transplant period could lead to more accurate recognition and more
speci®c and timely therapy of cutaneous GvHD, and could allow
measuring in real-time the response to therapy.
At present, we can observe leukocyte adhesion and rolling on the
endothelium with high contrast; however, when the leukocytes
migrate out of the blood vessel, they are not always easily seen
because the cells lack contrast relative to the surrounding
connective tissue. Methods to enhance the contrast of the
leukocytes must be developed, using either endogenous or
exogenous contrast agents.
We want to thank R.H. Webb, PhD and Thomas Flotte, MD for advice and
helpful discussion. This work is supported by a grant funded by Lucid, Inc. at the
Wellman Laboratories of Photomedicine, Massachusetts General Hospital.
Figure 1. Real time imaging of leukocyte traf®cking in human
papillary dermis in vivo. Sequential en-face optical sections of the same
microscopic plane of a super®cial basal cell carcinoma (BCC, see
elongated atypical nuclei, black arrows) demonstrate the rolling of
leukocytes (white arrow). Imaging depth corresponds to 90 mm below
the stratum corneum. Within papillary dermis, blood ¯ow (bf) through a
capillary loop (35 mm in diameter) is seen. The time period between
virtual sections a and c was 3 s. Note that blood ¯ow is more apparent
on active real-time video than on still, grabbed images. Individual
leukocytes (arrowheads) ®rmly adherent to the endothelial wall are also
visualized in real-time (1064 nm Nd:YAG laser; 60X, 0.85 NA. water
immersion objective lens; scale bar: 25 mm).
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Melanosomal pH, Pink Locus Protein and their Roles in
Melanogenesis
To the Editor:
We appreciate the opportunity to respond to the comments on our
recent article (Puri et al, 2000) by Ancans et al (2001).
Our hypothesis that the p protein functions to regulate
melanosome pH is based on the following observations:
1 Melanosomes are normally acidic. Indeed, more highly pigmen-
ted melanosomes are more acidic than less-pigmented melanosomes
(Moellmann et al, 1988; Bhatnagar et al, 1993; Ramaiah, 1996).
2 Melanosomes, as de®ned by organelles containing the melano-
somal marker protein, Tyrp1, are acidic in wild-type melanocytes,
but nonacidic in two independent melanocyte lines lacking
expression of the p protein (Puri et al, 2000).
3 The p protein is an integral melanosomal membrane protein
(Rosemblat et al, 1994).
4 The p protein is a 12 membrane spanning domain protein that
shares signi®cant homology with anion transporters (Rosemblat et
al, 1994; Lee et al, 1995; Brilliant, 2001), e.g., the oxyanion
translocating subunit of the ArsAB ATPase of bacteria, and several
dicarboxylate and sulfate transporters, revealed by BLAST search
algorithms.
5 Anion transporters are essential partners of vacuolar proton
pumps. Together they regulate the luminal pH of a variety of
intracellular organelles (Van Dyke, 1996; Grabe and Oster, 2001).
Whether the acidic conditions favor the enzymatic action of
tyrosinase or are required for other critical aspects of melanin
biosynthesis (e.g., the correct targeting of melanogenic proteins
such as Tyrp1 or biogenesis of melanosomes) is indeed an open
question as we indicated (Puri et al, 2000; Brilliant, 2001). As
pointed out by Ancans et al (2001), tyrosinase activity in vitro is
optimal at near neutral pH; however, it may very well be that the
in vivo activity of tyrosinase (where it is a melanosomal membrane
spanning protein) is optimal at a different pH (Devi et al, 1987).
Like Ancans et al (2001), we have also suggested that mistargeting of
melanosomal proteins may result from disregulation of melano-
somal pH (Puri et al, 2000; Brilliant, 2001), consistent with other
studies (Potterf et al, 1998; Orlow and Brilliant, 1999).
Acidi®cation of various intracellular compartments is important
for a number of processes, including receptor mediated endocytosis,
receptor recycling, and membrane traf®cking within the cell (Van
Dyke, 1996; Grabe and Oster, 2001).
We agree with Ancans et al (2001) that ``it is dif®cult to explain
how the p protein, which does not utilize energy from ATP, could
function against a proton gradient¼''. In fact, the p protein does
not function against a proton gradient. It works in concert with the
melanosome ATP-driven proton pump (Bhatnagar et al, 1993) that
is very likely the same pump present in endosomes, Golgi-derived
vesicles and lysosomes (Al-Awqati, 1995; Orlow, 1995). Based on
protein homology, the p protein is most likely an anion transporter.
Anion transporters are essential for the acidi®cation of these
organelle compartments by the ATP-driven proton pump (Van
Dyke, 1996; Grabe and Oster, 2001). Anion (Cl±, SO4
=, or
HCO3±) conductance provides the compensating charge balance to
electrogenic proton transport. We do not believe that the p protein
directly transports protons or other cations and we are unaware of
any data or protein homology algorithm demonstrating that the p
protein is homologous to the E. coli Na+/H+ antiporter as Ancans et
al (2001) state. The only statistically signi®cant homologies with
other proteins are to known anion transporters.
We accept the data by Ancans et al (2001) and by others (Ancans
and Thody, 2000; Fuller et al, 2001) that demonstrate increased
melanin synthesis in melanocytes that lack the p protein following
ba®lomycinA1, monensin, and NH4Cl treatment; however, in
these assays it would be important to know where this melanin
synthesis occurs. For example, increased tyrosine in the media
promotes increased melanin biosynthesis by p melanocytes (Sidman
and Pearlstein, 1965; Rosemblat et al, 1998), but this synthesis is not
primarily in melanosomes and the p protein is not a tyrosine
transporter (Gahl et al, 1995; Potterf et al, 1998).
In sum, we agree with Ancans et al (2001) that the relationship
between melanosomal pH and melanin biosynthesis is currently
unknown. Clearly further studies are warranted to understand the
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